Help - Search - Members - Calendar
Full Version: Anemia
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Anemia
Pages: 1, 2, 3, 4, 5, 6, 7, 8
  1. Anemia: Detecting chronic kidney disease in older people; what are the implications? (0 replies)
  2. Anemia: Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas (0 replies)
  3. Anemia: Insights into the ethnic differences in serum ferritin between black and white us adult men (0 replies)
  4. Anemia: Therapy of anemia in kidney failure, using plasmid encoding erythropoietin (0 replies)
  5. Anemia: Phase ii clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin (0 replies)
  6. Anemia: Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension (0 replies)
  7. Anemia: Pbi 1402 * has shown promise in the treatment of anaemia. (0 replies)
  8. Anemia: New erythropoietins (0 replies)
  9. Anemia: More action possible erythropoiesis-stimulating agents: us fda (0 replies)
  10. Anemia: Tacrolimus: cold agglutinin haemolytic anaemia in paediatric patients: 3 case reports (0 replies)
  11. Anemia: Fda to review new data on risks associated with anemia drugs (0 replies)
  12. Anemia: Fda to review data that find anemia drugs increase death risk, tumor growth in cancer patients (0 replies)
  13. Anemia: Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency: ferric-hf: a randomized, controlled, observer-blinded trial (0 replies)
  14. Anemia: Fda reviews new data on risks of erythropoiesis-stimulating agents (0 replies)
  15. Anemia: Fda reviewing anemia drugs again (0 replies)
  16. Anemia: Fda eyes anemia drugs' cancer risk again (0 replies)
  17. Anemia: Multiple neonatal haemangiomatosis with liver haemangiomas and anaemia (0 replies)
  18. Anemia: Fda to review new data on risks associated with anemia drugs (0 replies)
  19. Anemia: Fresh concerns about amgen's anemia drugs (0 replies)
  20. Anemia: Us fda issues update of ongoing safety review of erythropoiesis-stimulating agents (esas): epoetin alfa and darbepoetin alfa (0 replies)
  21. Anemia: Fda says more action possible on j&j, amgen drugs (0 replies)
  22. Anemia: Risks of anemia drugs in chemotherapy patients are bolstered (0 replies)
  23. Anemia: Clinical analysis of 43 patients with light chain multiple myeloma (0 replies)
  24. Anemia: Fda receives new data on risks of anemia drugs (0 replies)
  25. Anemia: Autoimmune hemolytic anemia in infancy and childhood (0 replies)
  26. Anemia: Phase ii study of capecitabine and cisplatin combination as first-line chemotherapy in chinese patients with metastatic nasopharyngeal carcinoma (0 replies)
  27. Anemia: A phase ii study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer (0 replies)
  28. Anemia: Nigeria: us-based citizen discovers sickle cell vaccine (0 replies)
  29. Anemia: Contributions of dna interstrand cross-links to aging of cells and organisms (0 replies)
  30. Anemia: Fda eyes anemia drugs' cancer risk again (0 replies)
  31. Anemia: Nigeria: american-based local doctor discovers treatment for sickle cell anaemia (0 replies)
  32. Anemia: Renal oncocytoma with bilateral synchronous renal cell carcinoma in a patient undergoing long-term hemodialysis (0 replies)
  33. Anemia: [letters] features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics (0 replies)
  34. Anemia: Midgut volvulus with hemorrhagic ascites: a rare cause of fetal anemia (0 replies)
  35. Anemia: Risk associated with preoperative anemia in cardiac surgery. a multicenter cohort study. (0 replies)
  36. Anemia: Improving outcomes of acute invasive aspergillus rhinosinusitis n patients with hematologici malignancies or aplastic anemia: the role of voriconazole. (0 replies)
  37. Anemia: A high rate of cll phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura. (0 replies)
  38. Anemia: Assessment of malaria in pregnancy using rapid diagnostic tests and its association with hiv infection and hematologic parameters in south-eastern nigeria. (0 replies)
  39. Anemia: Anemia in -thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. (0 replies)
  40. Anemia: Jak2v617f mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. (0 replies)
  41. Anemia: Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in japan by the prca collaborative study group. (0 replies)
  42. Anemia: Homologous recombination in dna repair and dna damage tolerance. (0 replies)
  43. Anemia: A prospective cohort study on anemia and blood transfusion in critically ill patients (0 replies)
  44. Anemia: Cerebral stroke associated with iron-deficiency anemia in toddlers (0 replies)
  45. Anemia: Successful coil embolization of a ruptured gastroduodenal artery aneurysm (0 replies)
  46. Anemia: Pernicious anemia (0 replies)
  47. Anemia: High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. (0 replies)
  48. Anemia: [asco special article] use of epoetin and darbepoetin in patients with cancer: 2007 american society of clinical oncology/american society of hematology clinical practice guideline update (0 replies)
  49. Anemia: Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. (0 replies)
  50. Anemia: Observations on iron deficiency anaemias in infancy and childhood (0 replies)
  51. Anemia: Aplastic anemia: pathophysiology and treatment edited by h schrezenmeier and a bacigalupo (0 replies)
  52. Anemia: Is there any difference between ferrous sulphate and ferrous gluconate in how long treatment of anaemia should be continued? (0 replies)
  53. Anemia: Danazol therapy for aplastic anemia refractory to immunosuppressive therapy (0 replies)
  54. Anemia: Major gene effect and additive familial pattern of inheritance of asthma exist among families of probands with sickle cell anemia and asthma (0 replies)
  55. Anemia: Images in clinical medicine: small-bowel intussusception (0 replies)
  56. Anemia: Congressional oversight of medicare program intensifies: a look at the factors surrounding the scrutiny and nephrology's response. (0 replies)
  57. Anemia: Building the chronic kidney disease management team. (0 replies)
  58. Anemia: Automation, decision support, and expert systems in nephrology. (0 replies)
  59. Anemia: Model predictive control of erythropoietin administration in the anemia of esrd. (0 replies)
  60. Anemia: Detection of cd55- and cd59-deficient granulocytic populations in patients with myelodysplastic syndrome (0 replies)
  61. Anemia: Rickets in children (an analysis of forty-two cases) (0 replies)
  62. Anemia: The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? (0 replies)
  63. Anemia: Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with aids (0 replies)
  64. Anemia: Elevated levels of somatic mutation in a manifesting brca1 mutation carrier. (0 replies)
  65. Anemia: Integrin {alpha}d 2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections. (0 replies)
  66. Anemia: Effects of ambient and dietary cadmium on haematological parametres in
    oreochromis mossambicus
    acclimatised to low- and high-calcium water     (0 replies)
  67. Anemia: A study of acute diffuse glomerulonephritis in children (0 replies)
  68. Anemia: Megaloblastic anaemia associated with thalassaemia (0 replies)
  69. Anemia: The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone (0 replies)
  70. Anemia: Initiation of antiretroviral therapy at cd4 cell counts >=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. (0 replies)
  71. Anemia: Incidence of anaemia and impact on sustained virological response in hiv/hcv-coinfected patients treated with pegylated interferon plus ribavirin (0 replies)
  72. Anemia: Amag pharmaceuticals, inc. submits new drug application to fda for ferumoxytol in chronic kidney disease patients (0 replies)
  73. Anemia: Use of epoetin and darbepoetin in patients with cancer: 2007 american society of hematology/american society of clinical oncology clinical practice guideline update (0 replies)
  74. Anemia: Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q (0 replies)
  75. Anemia: Effective erythropoiesis and hbf reactivation induced by kit ligand in -thalassemia (0 replies)
  76. Anemia: [original articles] delayed cord clamping in preterm infants delivered at 34 36 weeks' gestation: a randomised controlled trial (0 replies)
  77. Anemia: Cost and cost-effectiveness of nationwide school-based helminth control in uganda: intra-country variation and effects of scaling-up (0 replies)
  78. Anemia: Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients? (0 replies)
  79. Anemia: [reports] treatment of sickle cell anemia mouse model with ips cells generated from autologous skin (0 replies)
  80. Anemia: Nccn updates cancer- and treatment-related anemia guidelines (0 replies)
  81. Anemia: Anemia common in arthroplasty candidates (0 replies)
  82. Anemia: Hospira wins european approval for retacrit (0 replies)
  83. Anemia: Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance (0 replies)
  84. Anemia: Childhood myelodysplastic syndromes: clinical features, cytogenetics and prognosis (0 replies)
  85. Anemia: Nccn updates cancer- and treatment-related anemia guidelines (0 replies)
  86. Anemia: A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental plasmodium falciparum malaria (0 replies)
  87. Anemia: New drug application submitted to us fda for ferumoxytol for iron deficiency anaemia in patients with chronic kidney disease (0 replies)
  88. Anemia: Emea approves epoetin zeta (retacrit), a biosimilar erythropoietin (0 replies)
  89. Anemia: Anemia and iron status in young fertile non-professional female athletes (0 replies)
  90. Anemia: Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic ... (0 replies)
  91. Anemia: Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case (0 replies)
  92. Anemia: Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? (0 replies)
  93. Anemia: Early experience with conversion to sirolimus in a pediatric renal transplant population (49 replies)
  94. Anemia: Late introduction of sirolimus induces anemia in renal transplant recipients. (48 replies)
  95. Anemia: A few more minutes of maternal attachment may reduce anemia in children (0 replies)
  96. Anemia: Fda panel wants more anemia drug studies (0 replies)
  97. Anemia: Fda panel wants more anemia drug studies
    (ap)     (0 replies)
  98. Anemia: Fda panel warns of anemia drug risks (0 replies)
  99. Anemia: May 11, 2007: in the news (0 replies)
  100. Anemia: Fda documents question safety of anemia medications in advance of meeting (0 replies)
  101. Anemia: Limits on anemia drug are advised (0 replies)
  102. Anemia: Fda panel wants anemia drug warnings (0 replies)
  103. Anemia: Fda advisory committee recommends new restrictions for anemia medications (0 replies)
  104. Anemia: Fda panel questions safety of anemia drug (0 replies)
  105. Anemia: Fda panel wants more anemia drug studies (0 replies)
  106. Anemia: Analysis: panel urges anemia drug limits (0 replies)
  107. Anemia: Should patients with pernicious anaemia (positive for gastric parietal antibodies) undergo routine gastroscopy to detect atrophic gastritis (0 replies)
  108. Anemia: Fda panel wants anemia drug warnings (0 replies)
  109. Anemia: Ins and outs (0 replies)
  110. Anemia: Statement from uspstf: screening for iron deficiency anemia -- including iron supplementation for children and pregnant women (0 replies)
  111. Anemia: The myelodysplastic syndromes, aplastic anemia, and paroxysmal nocturnal hemoglobinuria: evolution to acute leukemia, and therapy (0 replies)
  112. Anemia: The anemia of achylia gastrica revisited. (0 replies)
  113. Anemia: Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype. (0 replies)
  114. Anemia: The fanconi family adds a fraternal twin. (0 replies)
  115. Anemia: Birth control pills' diabetes risk, safety for sickle cell patients unclear (0 replies)
  116. Anemia: Omeprazole: autoimmune haemolytic anaemia in an elderly patient: case report (0 replies)
  117. Anemia: Laboratory medicine in primary care: investigating iron status in microcytic anaemia (0 replies)
  118. Anemia: Drug company says patient dies in anemia drug trial
    (reuters)     (0 replies)
  119. Anemia: In cancer-related anemia researchers warn caution in the use of esas (0 replies)
  120. Anemia: In cancer-related anemia researchers warn caution in the use of esas (0 replies)
  121. Anemia: Steroidal hormones for contraception in women with sickle cell disease (0 replies)
  122. Anemia: Type i interferon signaling and b cells maintain hemopoiesis during pneumocystis infection of the lung. (0 replies)
  123. Anemia: Recombinant human ifn-{alpha} inhibits cerebral malaria and reduces parasite burden in mice. (0 replies)
  124. Anemia: Birth control pills' diabetes risk, safety for sickle cell patients unclear (0 replies)
  125. Anemia: Birth control pills' diabetes risk, safety for sickle cell patients unclear (0 replies)
  126. Anemia: Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with diamond-blackfan anemia: case report. (0 replies)
  127. Anemia: Recognizing the link between ckd and cvd in the primary care setting: accurate and early diagnosis for timely and appropriate intervention. (0 replies)
  128. Anemia: Recombinant erythropoietin favoured in chemo-related anaemia. (0 replies)
  129. Anemia: The radiological manifestations of sickle cell disease. (0 replies)
  130. Anemia: Anemia is associated with mortality in kidney-transplanted patients–a prospective cohort study (0 replies)
  131. Anemia: Scleral necrosis in a patient with aplastic anaemia (0 replies)
  132. Anemia: [metabolism and bioenergetics] magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with plasmodium berghei anka (0 replies)
  133. Anemia: Bmp4, scf, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors (0 replies)
  134. Anemia: Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens (0 replies)
  135. Anemia: Granulocyte colony-stimulating factor and severe aplastic anemia (0 replies)
  136. Anemia: Response: g-csf and aplastic anemia (0 replies)
  137. Anemia: Anemia treatment varies between profits, nonprofits (0 replies)
  138. Anemia: Discrimination indices as screening tests for β-thalassemic trait (0 replies)
  139. Anemia: Drainage does not increase anemia after cementless total hip arthroplasty. (0 replies)
  140. Anemia: A phase i study of sulofenur in refractory pediatric malignant solid tumors (0 replies)
  141. Anemia: Correspondence: case 40-2006: anemia and low hdl cholesterol (0 replies)
  142. Anemia: The overlap of overweight and anaemia among women in three countries undergoing the nutrition transition (0 replies)
  143. Anemia: Caution against over-aggressive use of erythropoiesis-stimulating agents for cancer-related anemia (0 replies)
  144. Anemia: Health technology assessment (hta) (0 replies)
  145. Anemia: An otherwise healthy five year old girl has continually high alp levels. blood and urine tests have not unearthed the cause. what could be causing these high scores? (0 replies)
  146. Anemia: The long-term outcome in surviving infants with apgar zero at 10 minutes: a systematic review of the literature and hospital-based cohort. (0 replies)
  147. Anemia: Evidence-based practices for the fetal to newborn transition. (0 replies)
  148. Anemia: Medical news & perspectives: fda sounds alert on anemia drugs (0 replies)
  149. Anemia: Anemia a concern among low-income preschoolers (0 replies)
  150. Anemia: Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in khuzestan province of iran (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.